14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 02, 2026
MLEC vs LVRO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 02, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over Lavoro Limited Class A (LVRO) on higher Unified Composite conviction (40.8/100 SELL vs. 41.1/100 SELL) after splitting the core matrix 3–6 (led by composite factor balance), while LVRO wins 5–0 across the 6-pillar growth and valuation breakdown. MLEC trades at $0.85 (N/M Forward P/E, 0.0% operating margin) versus LVRO at $0.30 (63.7x Forward P/E, 0.2% operating margin).
Growth vs. Quality Trade-Off: MLEC earns the overall head-to-head edge with a stronger Unified Composite Score (40.8/100 SELL vs. LVRO 41.1/100 SELL) and 0.05β · 208% Vol risk profile, whereas LVRO leads top-line expansion (-13.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although MLEC compares more favorably head-to-head, both MLEC (40.8/100 SELL) and LVRO (41.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: MLEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8); meanwhile LVRO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLEC vs LVRO. Trailing 12-month operating profitability (MLEC 0.0% vs LVRO 0.2%) and valuation multiples (MLEC N/M vs LVRO 63.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Agricultural Inputs value chain with $60.8M market capitalization and 0.2% operating margin.
OpEx & R&D Reinvestment14.8% of Rev ($1.34B)
90D Engineering Disclosures0 Published
Investor FAQ MLEC vs LVRO Key Questions & Quantitative Answers
As of Nov 02, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over Lavoro Limited Class A (LVRO) on higher Unified Composite conviction (40.8/100 SELL vs. 41.1/100 SELL) after splitting the core matrix 3–6 (led by composite factor balance), while LVRO wins 5–0 across the 6-pillar growth and valuation breakdown. MLEC trades at $0.85 (N/M Forward P/E, 0.0% operating margin) versus LVRO at $0.30 (63.7x Forward P/E, 0.2% operating margin). Growth vs. Quality Trade-Off: MLEC earns the overall head-to-head edge with a stronger Unified Composite Score (40.8/100 SELL vs. LVRO 41.1/100 SELL) and 0.05β · 208% Vol risk profile, whereas LVRO leads top-line expansion (-13.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although MLEC compares more favorably head-to-head, both MLEC (40.8/100 SELL) and LVRO (41.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: MLEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8); meanwhile LVRO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
LVRO leads the Growth & Scale pillar: MLEC posts +948.3% YoY revenue growth and +0.0% YoY earnings growth on $7.8M TTM revenue (-8.2% gross margin, 0.0% operating margin), compared with LVRO at -13.2% YoY revenue growth and +0.0% YoY earnings growth on $9.08B TTM revenue (15.0% gross margin, 0.2% operating margin). On trailing 12-month operating scale, MLEC generates $7.8M in USD-normalized revenue versus $9.08B for LVRO. In operating R&D and SG&A reinvestment, MLEC deploys N/A (0 90-day corporate R&D disclosures) versus 14.8% of Rev ($1.34B) (0 disclosures) for LVRO.
LVRO screens cheaper on headline valuation multiples. MLEC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-103.1% EBITDA margin), whereas LVRO trades at 63.7x Forward P/E, 63.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (1.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MLEC (-174.7% ROE) versus LVRO (-62.4% ROE) capital efficiency.
In options market volatility and institutional positioning, MLEC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.05β · 208% Vol realized risk). By comparison, LVRO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 160% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 02, 2026. For educational research only; not investment advice.